Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study (Journal of Neurology, (2023), 10.1007/s00415-023-11700-7)

The original version of this article unfortunately contained a mistake. The several values in Table 1 have shifted up from the correct row. Category of N Previous treatments, N%” has 4 sub-entries, with which the values should be aligned. And the same is for “Type of Last Previous Treatments, N%”, which has 7 sub-entries with which the values should be aligned. The corrected Table 1 is given in the following page.